N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity
Plasmodium falciparum, the causative agent of the most lethal form of malaria, is becoming increasingly resistant to most available drugs. A convenient approach to combat parasite resistance is the development of analogues of classical antimalarial agents, appropriately modified in order to restore their relevance in antimalarial chemotherapy.
Ler mais
